Bloomberg: Cancer’s Soaring Cost Wrecks Patients’ Finances in a Broken System

As part of the Inflation Reduction Act in 2022, Congress capped patient out-of-pocket costs at $2,000 in the Medicare prescription drug program. Trapp, who’s now a patient advocate for a non-profit group called Patients for Affordable Drugs, said that helped limit her own expenses once she qualified for Medicare through disability. But the cap only applies to drugs taken at home like pills and not other treatment for cancer patients, like chemotherapy or infusions.